Tacrolimus: all 596 studies that test it
Page 5 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy VolunteersCompletedNCT01430065Phase 1
- Tacrolimus Versus Cyclosporine for Immunosuppression After Lung TransplantationCompletedNCT01429844Phase 3
- Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisCompletedNCT01418131Phase 4
- Advagraf/Prograf Conversion TrialCompletedNCT01410162Phase 4
- Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4
- A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsTerminatedNCT01371344Phase 4
- A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ TransplantationCompletedNCT01371331Phase 4
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsTerminatedNCT01342016Phase 3
- A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationCompletedNCT01339468Phase 4
- Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant RecipientsCompletedNCT01334333Phase 4
- Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult VitiligoStatus unknownNCT01333410Phase 4
- Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®CompletedNCT01332201Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus NephritisCompletedNCT01328834Phase 3
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisCompletedNCT01325571Phase 3
- A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)CompletedNCT01309477Phase 3
- A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsCompletedNCT01304836Phase 4
- Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®CompletedNCT01294020Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus NephritisWithdrawnNCT01288664Phase 3
- Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
- A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224418Phase 4
- Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224041Phase 4
- A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsCompletedNCT01224028Phase 2
- Tacrolimus Versus Cyclophosphamide as Treatment for Lupus NephritisCompletedNCT01207297Phase 1
- A Study to Evaluate the Drug Interaction of ASP015K and TacrolimusCompletedNCT01190670Phase 1
- Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft RecipientsCompletedNCT01160276Phase 1
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting ConditionsCompletedNCT01132027Phase 1
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01131988Phase 1
- Insulin Secretion and AdvagrafCompletedNCT01092806Phase 4
- Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic SyndromeCompletedNCT01084980Phase 2/3
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed ConditionCompletedNCT01080534Not applicable
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting ConditionCompletedNCT01080482Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed ConditionCompletedNCT01080469Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting ConditionCompletedNCT01080456Not applicable
- Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)CompletedNCT01068054Phase 2/3
- Safety and Tolerability of LIM-0705 in Healthy Male SubjectsCompletedNCT01060475Phase 1
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisCompletedNCT01056237Not applicable
- a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft RecipientsCompletedNCT01055964Phase 3
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy AdultsCompletedNCT01038167Phase 1
- A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation PatientsCompletedNCT01018914Phase 4
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
- Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant PatientsStatus unknownNCT00987103Phase 1
- Bayesian Dose Adjustment of Immunosuppressants After Lung TransplantationTerminatedNCT00975663Phase 4
- Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisStatus unknownNCT00956059Not applicable
- Enhancement of Functional Recovery After Peripheral Nerve Injury With TacrolimusWithdrawnNCT00950391Phase 1/2
- Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal TransplantationCompletedNCT00935298Phase 4
- Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung TransplantationTerminatedNCT00930241Phase 3
- Minimizing Immunosuppression in Old for Old Kidney TransplantationCompletedNCT00912678Phase 4
- Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusCompletedNCT00909571Phase 3
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Benefit of Early Protocol Biopsy and Treatment of Subclinical RejectionCompletedNCT00885820Phase 4
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingNCT00882895Phase 2
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
- Assess the Efficacy and Safety of Multi-target Therapy in Lupus NephritisCompletedNCT00876616Not applicable
- An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant RecipientsCompletedNCT00865137Phase 3
- Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
- Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy VolunteersCompletedNCT00818194Phase 1
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
- Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus PlaceboCompletedNCT00807690Phase 3
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
- Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal TransplantationCompletedNCT00777933Not applicable
- Diabetogenicity of Cyclosporine and TacrolimusCompletedNCT00766909Phase 4
- Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen SclerosusCompletedNCT00757874Phase 2
- Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal TransplantationCompletedNCT00724022Phase 4
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.CompletedNCT00720408Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation PatientsCompletedNCT00720265Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant RecipientsCompletedNCT00719745Phase 3
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant RecipientsCompletedNCT00717678Phase 3
- A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney RejectionCompletedNCT00717470Phase 4
- Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
- A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus CorticosteroidsStatus unknownNCT00693446Phase 4
- Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney TransplantationCompletedNCT00693381Phase 3
- Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
- Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
- Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
- Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
- Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney TransplantationCompletedNCT00681213Phase 4
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationCompletedNCT00670423Phase 1
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
- Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact DermatitisCompletedNCT00667056Phase 4
- A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
- A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant PatientsCompletedNCT00650468Phase 4
- Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNCT00643071Phase 3
- Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)CompletedNCT00637143Phase 4
- Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy SubjectsCompletedNCT00621699Phase 1
- A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation PatientsCompletedNCT00619398Phase 3
- Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)CompletedNCT00615667Phase 3
- Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisCompletedNCT00615173Phase 3
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell TransplantationCompletedNCT00612274Early Phase 1
- Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver TransplantationCompletedNCT00609388Phase 4
- A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus NephritisStatus unknownNCT00569101Phase 2
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567918Phase 3
- Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567762Phase 3
- Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2